CEACAM5 and myeloid sarcoma: Conversely, variables such as sex, age, BMI, smoking history, metabolic syndrome (MS), preoperative CEA level, tumor morphology (pedunculated or sessile), and the number of tumors did not exhibit a significant association with pathological upgrade (P > 0.05).